Financings Of The Fortnight: Movetis Files First European Biopharma IPO Since Early 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
Notable biotech financings in November also include ThromboGenics, NicOx: 4SC AG, and Fate Therapeutics.